4//SEC Filing
Chaubey Alka 4
Accession 0001415889-24-015619
CIK 0001411690other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 5:40 PM ET
Size
8.0 KB
Accession
0001415889-24-015619
Insider Transaction Report
Form 4
Chaubey Alka
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-06-03+75,000→ 75,000 totalExercise: $0.93Exp: 2034-06-02→ Common Stock (75,000 underlying) - Award
Common Stock
2024-06-03+16,000→ 48,245 total
Footnotes (4)
- [F1]Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.
- [F2]The shares subject to the RSUs vest 1/4th annually beginning on the one-year anniversary of the grant date.
- [F3]Includes 150 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 9, 2023 and 608 shares acquired under the ESPP from previous years.
- [F4]The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of June 3, 2024 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.
Documents
Issuer
Bionano Genomics, Inc.
CIK 0001411690
Entity typeother
Related Parties
1- filerCIK 0001821605
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 5:40 PM ET
- Size
- 8.0 KB